DNMT1 and posterior cortical atrophy: Our study in hormone-dependent cancers supports the potential of novel combinatorial approach involving the administration of GSK3 inhibitors with DNMT inhibitors to augment the sensitivity of PCa and BCa cells to existing inhibitors of the AR and ER, respectively.